1. Home ➔
  2. Peptides ➔
  3. Neuropeptides
  • Neuropeptide Y (13-36) (human, rat)

Neuropeptide Y (13-36) (human, rat)

Not For Human Use, Lab Use Only.

Cat.#: 309624

Size:

* Buy 1 get 1 free (?) What is TFA?

Special Price 303.60 USD

Availability: 3 weeks

Add to cart to get an online quotation

Product Information

  • Product Name
    Neuropeptide Y (13-36) (human, rat)
  • Documents
  • Sequence Shortening
    PAEDMARYYSALRHYINLITRQRY
  • Sequence
    H-Pro-Ala-Glu-Asp-Met-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Leu-Ile-Thr-Arg-Gln-Arg-Tyr-NH2
  • Length (aa)
    24
  • Peptide Purity (HPLC)
    97.6%
  • Molecular Formula
    C134H207N41O36S
  • Molecular Weight
    3000.44
  • CAS No.
    122341-40-6
  • Source
    Synthetic
  • Form
    Powder
  • Description

    Neuropeptide Y (13-36) (human, rat) is a C-terminal fragment of the parent peptide neuropeptide Y (1-36). It is characterized as a selective agonist at Y2-type neuropeptide Y receptors, which are distinguished from Y1 receptors by their high affinity for long C-terminal fragments such as NPY (13-36). The fragment requires its C-terminal segment for full biological activity and is distributed within the central nervous system, where Y2 receptors are expressed.

    In central cardiovascular regulation, centrally administered NPY (13-36) produces a dose-dependent vasopressor response in the awake, unrestrained male rat, increasing mean arterial blood pressure without affecting heart rate. This pressor action contrasts with the vasodepressor and bradycardic effects of the parent molecule NPY (1-36), which preferentially activates Y1 receptors. A subthreshold dose of NPY (13-36) can counteract the vasodepressor action of NPY (1-36) without modifying its bradycardic effect, suggesting that Y1 and Y2 receptor populations exert opposing actions in central cardiovascular control, possibly through G-protein-mediated interactions. These findings support the concept that active peptide fragments formed from the parent peptide may participate in the regulation of central networks via distinct receptor subtypes.

  • Storage Guidelines
    Normally, this peptide will be delivered in lyophilized form and should be stored in a freezer at or below -20 °C. For more details, please refer to the manual: Handling and Storage of Synthetic Peptides
  • References
    • Aguirre JA, Fuxe K, Agnati LF, von Euler G. Centrally injected neuropeptide Y (13-36) produces vasopressor effects and antagonizes the vasodepressor action of neuropeptide Y (1-36) in the awake male rat. Neurosci Lett. 1990 Oct 2;118(1):5-8. doi: 10.1016/0304-3940(90)90235-2. PMID: 2259468.
  • About TFA salt

    Trifluoroacetic acid (TFA) is a common counterion from the purification process using High-Performance Liquid Chromatography (HPLC). The presence of TFA can affect the peptide's net weight, appearance, and solubility.

    Impact on Net Weight: The TFA salt contributes to the total mass of the product. In most cases, the peptide content constitutes >80% of the total weight, with TFA accounting for the remainder.

    Solubility: TFA salts generally enhance the solubility of peptides in aqueous solutions.

    In Biological Assays: For most standard in vitro assays, the residual TFA levels do not cause interference. However, for highly sensitive cellular or biochemical studies, please be aware of its presence.

  • Molar Concentration Calculator
  • Dilution Calculator
  • Percent Concentration Calculator

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass
=
Concentration
×
Volume
×
Molecular Weight

• Peptide Services: NovoPro's peptide synthesis services include standard chemical peptide synthesis, peptide modification, peptide libraries, and recombinant peptide expression.

• Standard Peptide Synthesis: NovoPro offers quality peptides at the most competitive prices in the industry, starting at $3.20 per amino acid. NovoPro provides PepBox – Automatic Quote Tool for online price calculation.

• Peptide Modifications: NovoPro offers a wide range of peptide modification services including isotope labeling (2H, 15N, and 13C), multiple disulfide bonds, multiple phosphorylations, KLH, BSA, ovalbumin, amidation, acetylation, biotin, FITC, etc.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"